The Australian Women’s Health market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
In 2018, just over half of Australia’s population—51% or 12.6 million people—were female. On average, Australian females experience different health outcomes than Australian males. Compared with males, females have a higher life expectancy and experienced more of their total disease burden due to living with the disease rather than from dying early from disease and injury. Women’s health includes all of the therapeutics, drugs, and surgical offerings precautionary measures for the various disorders associated with the women population. These disorders vary from nutrition, oncology, reproductive, menopause, urological as well as other Health applications. Women’s health is focused on providing better management of diseases and improving the overall health of the women population.
The increasing prevalence of preventing women-related health disorders by the population and authorities is expected to promote the market value. The rise in the levels of research & development initiatives undertaken by various manufacturers in providing better health services for women is expected to positively affect the growth of the market as well. Lack of qualitative Health services for women from the under-developed regions of the world is expected to provide better areas for growth of the market value. Changes in the lifestyle of individuals coupled with bad nutritional intake are factors driving the growth of the market.
Major Women’s Health Disease Indication
The leading cause of death for females in 2017 was Dementia and Alzheimer disease. Fewer than 1 in 10 women ate the recommended amount of fruit and vegetables in 2017–18. The leading cause of total disease burden for females in 2015 was coronary heart disease. In 2015, females experienced a smaller share of the total disease burden (47%) than males (53%). A larger proportion of the total disease burden for females was caused by living with the disease. For males, the greatest proportion of total burden was caused by premature death.
The distribution of overall burden between the sexes varied by disease group. Compared with males, females experience a greater proportion of the total burden from:
- blood and metabolic disorders (59%)
- neurological conditions (58%)
- musculoskeletal conditions (55%).
Nearly half (44%) of the total burden of disease for females is from cancer, musculoskeletal conditions, and cardiovascular disease.